News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
56,814 Results
Type
Article (3610)
Company Profile (13)
Press Release (53191)
Section
Business (21485)
Career Advice (66)
Deals (3820)
Drug Delivery (10)
Drug Development (4086)
Employer Resources (12)
FDA (827)
Job Trends (1064)
News (29169)
Policy (1311)
Tag
2024 BioCapital Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (1)
Academia (237)
Allergies (3)
Alliances (5163)
ALS (5)
Alzheimer's disease (119)
Antibody-drug conjugate (ADC) (6)
Approvals (826)
Artificial intelligence (40)
Autoimmune disease (2)
Bankruptcy (32)
Best Places to Work (755)
BIOSECURE Act (2)
Biosimilars (7)
Biotechnology (13)
Bladder cancer (4)
Brain cancer (1)
Breast cancer (12)
Cancer (115)
Cardiovascular disease (9)
Career advice (59)
Career pathing (3)
CAR-T (13)
Cell therapy (33)
Clinical research (3115)
Collaboration (75)
Compensation (2)
Complete response letters (1)
COVID-19 (157)
CRISPR (4)
C-suite (36)
Cystic fibrosis (14)
Data (117)
Denatured (2)
Depression (4)
Diabetes (13)
Diagnostics (574)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (18)
Drug pricing (11)
Duchenne muscular dystrophy (3)
Earnings (4321)
Editorial (4)
Employer resources (10)
Events (5201)
Executive appointments (112)
FDA (889)
Featured Employer (2)
Friedreich's ataxia (1)
Funding (343)
Gene editing (10)
Generative AI (3)
Gene therapy (25)
GLP-1 (64)
Government (125)
Guidances (4)
Healthcare (1261)
Huntington's disease (1)
IgA nephropathy (3)
Immunology and inflammation (14)
Indications (1)
Infectious disease (165)
Inflammatory bowel disease (12)
Inflation Reduction Act (4)
Influenza (1)
Intellectual property (9)
Interviews (5)
IPO (1776)
IRA (8)
Job creations (319)
Job search strategy (57)
Labor market (5)
Layoffs (32)
Leadership (1)
Legal (275)
Liver cancer (3)
Lung cancer (16)
Lymphoma (6)
Machine learning (1)
Management (4)
Manufacturing (26)
MASH (6)
Medical device (1270)
Medtech (1272)
Mergers & acquisitions (2103)
Metabolic disorders (54)
Multiple sclerosis (2)
NASH (1)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (153)
NextGen: Class of 2025 (968)
Non-profit (289)
Northern California (217)
Now hiring (1)
Obesity (35)
Opinion (47)
Ovarian cancer (3)
Pain (6)
Pancreatic cancer (1)
Parkinson's disease (9)
Partnered (4)
Patents (8)
Patient recruitment (8)
Peanut (3)
People (8749)
Pharmaceutical (4)
Phase I (1055)
Phase II (1443)
Phase III (877)
Pipeline (63)
Podcasts (5)
Policy (14)
Postmarket research (96)
Preclinical (576)
Press Release (6)
Prostate cancer (6)
Psychedelics (2)
Radiopharmaceuticals (25)
Rare diseases (32)
Real estate (577)
Recruiting (5)
Regulatory (988)
Reports (3)
Research institute (167)
Resumes & cover letters (9)
RNA editing (1)
Schizophrenia (4)
Series A (93)
Series B (67)
Service/supplier (1)
Sickle cell disease (1)
Southern California (154)
Special edition (2)
Spinal muscular atrophy (1)
Sponsored (1)
Startups (2171)
Supply chain (4)
The Weekly (3)
United States (1387)
Vaccines (25)
Venture capitalists (35)
Webinars (4)
Weight loss (18)
Women's health (2)
Date
Today (11)
Last 7 days (55)
Last 30 days (224)
Last 365 days (2759)
2025 (702)
2024 (2930)
2023 (3085)
2022 (5515)
2021 (4850)
2020 (4690)
2019 (4325)
2018 (3478)
2017 (3046)
2016 (2538)
2015 (2928)
2014 (2110)
2013 (1749)
2012 (1869)
2011 (2087)
2010 (2169)
Location
Africa (63)
Alabama (5)
Alaska (2)
Arizona (10)
Arkansas (5)
Asia (4065)
Australia (484)
California (471)
Canada (418)
China (39)
Colorado (13)
Connecticut (24)
Delaware (5)
Europe (8115)
Florida (29)
Georgia (14)
Idaho (5)
Illinois (40)
India (5)
Indiana (18)
Iowa (1)
Japan (21)
Kansas (7)
Kentucky (1)
Louisiana (4)
Maine (6)
Maryland (42)
Massachusetts (277)
Michigan (8)
Minnesota (13)
Missouri (9)
Nevada (1)
New Hampshire (5)
New Jersey (71)
New Mexico (4)
New York (100)
North Carolina (56)
Northern California (217)
Ohio (22)
Oklahoma (3)
Oregon (2)
Pennsylvania (45)
Puerto Rico (3)
South America (100)
South Carolina (1)
Southern California (154)
Tennessee (8)
Texas (57)
Utah (14)
Virginia (8)
Washington D.C. (1)
Washington State (29)
Wisconsin (6)
56,814 Results for "tpg ventures".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology
TPG and AmerisourceBergen Corporation (NYSE: ABC) today announced the completion of their previously announced acquisition of OneOncology, a network of leading oncology practices.
June 9, 2023
·
2 min read
Press Releases
SNBL and Tasso, Inc. to Establish Joint Venture in Japan
March 28, 2025
·
2 min read
Business
TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network OneOncology From General Atlantic
TPG (NASDAQ: TPG), a global alternative asset management firm, and AmerisourceBergen Corporation (NYSE: ABC) today announced that they have agreed to acquire OneOncology, a network of leading oncology practices, from General Atlantic, a leading global growth equity firm.
April 20, 2023
·
12 min read
Press Releases
Astellas and YASKAWA Agree to Establish a Joint Venture Focused on Cell Therapy Manufacturing
March 6, 2025
·
4 min read
Press Releases
FELDAN THERAPEUTICS ACCELERATES GROWTH WITH STRATEGIC INVESTMENT FROM LINEARIS VENTURES
February 18, 2025
·
2 min read
BioMidwest
Saluda Medical Announces $150M Equity Financing Led by Wellington Management with Fidelity Management & Research Company and TPG
Saluda Medical Inc. announced the closing of a US $150 million equity financing round led by new investor Wellington Management, with strong support from current investor Fidelity Management & Research Company and new investor TPG.
April 13, 2023
·
3 min read
Press Releases
Qolab Secures Investment from Applied Ventures and Announces Collaboration to Advance Quantum Computing Manufacturing
March 17, 2025
·
2 min read
Press Releases
Harness Therapeutics appoints Dr Heather Preston as Chair and secures new funding from Ono Venture Investment to accelerate delivery of transformational neurodegeneration pipeline
January 27, 2025
·
5 min read
Startups
BridgeBio Launches GondolaBio With $300M, Transfers Programs to Joint Venture
With the help of third-party investors, the new venture will focus on three genetic and rare diseases: tuberous sclerosis complex, erythropoietic protoporphyria and alpha-A1 antitrypsin deficiency.
August 22, 2024
·
2 min read
·
Tristan Manalac
BioMidwest
Sudo Biosciences Raises $116M Series B Financing to Advance Potential Best-in-Class TYK2 Therapeutics Programs into the Clinic
Sudo Biosciences announced the close of a $116 million Series B financing round co-led by Enavate Sciences and TPG, which is investing in the company through TPG Life Sciences Innovations and The Rise Fund, with participation from Sanofi Ventures, Surveyor Capital, Monograph Capital, and Eventide Asset Management as well as existing investors Frazier Life Sciences and Velosity Capital.
December 20, 2023
·
4 min read
1 of 5,682
Next
